The clinical, serological and myopathological features of a cohort of Chinese patients with inclusion body myositis: a single center analysis
Authors:
Open Access
- 5 March 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1782053
Abstract
Background: This study aimed to investigate the clinical, serological and myopathological features of Chinese patients with inclusion body myositis (IBM). Methods: This study retrospectively recruited patients diagnosed with IBM according to the 2024 European Neuromuscular Center (ENMC) criteria at Peking University First Hospital between 2004 and 2024. Clinical features, pathological changes and laboratory data were collected. Subgroups were analyzed by sex, dysphagia, anti-cN1A antibody status, and complement deposition. Results: Forty-three IBM patients (25 males) were included in this cohort. The mean age at onset was 54.9 ± 9.6 years old. All the patients developed weakness in hip flexion, and 81.4% of them with weakness in both knee extension and finger flexion. Dysphagia was reported in 17 patients (39.5%). Endomysial inflammation was observed in all the patients, and 79.1% with rimmed vacuoles, and 76.9% with mitochondrial abnormalities. Female patients more frequently developed dysphagia (P = 0.005) and neck flexion weakness (P < 0.001). Anti-cN1A antibody was positive in 20 patients (66.7%). Seropositive cases were associated with a later age of onset (P = 0.034). Complement deposition was observed in 77.4% of patients and was associated with more severe muscle weakness. Conclusion: This cohort of Chinese IBM patients suggested an earlier age at onset than previously reported. Hip flexors were most commonly affected. Female patients showed a higher frequency of dysphagia and neck flexor weakness. Our study reported a high frequency of complement deposition in muscle tissue. Complement deposition was associated with disease severity, suggesting a potential role of complement in the pathophysiology of IBM.Keywords
Funding Information
- National Natural Science Foundation of China (81801243, 82430059)
This publication has 44 references indexed in Scilit:
- Age and sex differences in sarcopenic dysphagia: A secondary data analysisJournal of General and Family Medicine, 2024
- Atypical presentations of inclusion body myositis: Clinical characteristics and long‐term outcomesMuscle & Nerve, 2022
- Epidemiology, Survival, and Clinical Characteristics of Inclusion Body MyositisAnnals of Neurology, 2022
- Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathiesAnnals of Clinical and Translational Neurology, 2021
- Anti‐cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositisMuscle & Nerve, 2020
- Long‐term strength and functional status in inclusion body myositis and identification of trajectory subgroupsMuscle & Nerve, 2020
- Pathomechanisms of anti–cytosolic 5′‐nucleotidase 1A autoantibodies in sporadic inclusion body myositisAnnals of Neurology, 2017
- A surprising case of inclusion body myositis with positive endomysial C5b-9 stainingMuscle & Nerve, 2016
- Cytosolic 5′‐Nucleotidase 1A As a Target of Circulating Autoantibodies in Autoimmune DiseasesArthritis Care & Research, 2015
- Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositisAnnals of Neurology, 2012